EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Combining lefamulin with rifampin provides in vitro synergistic antimicrobial effects against Rhodococcus equi isolates susceptible to macrolides and rifampin

Sally F O Alpini, Marlane G Seeger, Bibiana P da Silveira, Cierra A Cadena, Elaine Pham, Laura Huber, Angela I Bordin, Jing Wu, Sara D Lawhon, Noah D Cohen iD

American Journal of Veterinary Research · 01.11.2026 · 87 (11)

DOI: 10.2460/ajvr.26.05.0213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.11.2026. Verfasst von Sally F O Alpini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M U…. Hauptthemen laut MEDLINE: Rifampin, Rhodococcus equi, Anti-Bacterial Agents, Macrolides. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Because of lefamulin’s antimicrobial spectrum and intrapulmonary disposition, the objective of this study was to estimate MICs for macrolide- and rifampin-susceptible (MRS) and macrolide- and rifampin-resistant (MRR) isolates of Rhodococcus equi to lefamulin either alone or in combination with rifampin.

Methods

Gradient diffusion and broth microdilution were performed to determine MICs for lefamulin alone using MRS (n = 43) and MRR isolates (61) of R equi . Twenty MRR and 20 MRS isolates were tested for synergistic effects using a checkerboard assay and the fractional inhibitory concentration index as an outcome measure.

Results

For both MRR and MRS isolates, MIC values were significantly higher using broth microdilution (median MIC, 32 µg/mL; range, 8 to 64 µg/mL) than gradient diffusion (median MIC, 12 µg/mL; range, 5 to 28 µg/mL) testing. The fractional inhibitory concentration values of MRR isolates (median, 0.562; range, 0.250 to 1.000) were significantly higher than those of MRS isolates (median, 0.280; range, 0.039 to 1.038). In addition, the proportion of isolates exhibiting synergistic interaction was significantly greater among MRS isolates (16 of 20 [80%]) than among MRR isolates (6 of 20 [30%]).

Conclusions

Overall, the MIC values for lefamulin against R equi were high relative to concentrations considered therapeutic in humans. When combined with rifampin, lefamulin exhibited synergistic effects for MRS but not MRR isolates. Clinical Relevance Need exists for alternative antimicrobials to treat rhodococcal foal pneumonia. Results indicate that studies in foals of the pharmacokinetics and pulmonary disposition of lefamulin in combination with rifampin are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinRhodococcus equiAnti-Bacterial AgentsMacrolidesNaphthalenesDiterpenesMicrobial Sensitivity TestsDrug SynergismAnimalsDrug Resistance, BacterialPolycyclic CompoundsThioglycolates

Stichwörter der Autor:innen

Rhodococcus equilefamulinresistancerifampinsusceptibility testing

Substanzen

RifampinAnti-Bacterial AgentsMacrolideslefamulinNaphthalenesDiterpenesPolycyclic CompoundsThioglycolates

Autor:innen und Institutionen

  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX.
  • Department of Veterinary Preventive Medicine, Faculty of Veterinary Medicine, Federal University of Santa Maria, Santa Maria,Brazil.
  • Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX.
  • Department of Veterinary Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL.

ORCID-Profile: Noah D Cohen

Zitieren

APA

Alpini, S. F. O., Seeger, M. G., da Silveira, B. P., Cadena, C. A., Pham, E., Huber, L., Bordin, A. I., Wu, J., Lawhon, S. D., & Cohen, N. D. (2026). Combining lefamulin with rifampin provides in vitro synergistic antimicrobial effects against Rhodococcus equi isolates susceptible to macrolides and rifampin. American Journal of Veterinary Research, 87(11). https://doi.org/10.2460/ajvr.26.05.0213

Vancouver

Alpini SFO, Seeger MG, da Silveira BP, Cadena CA, Pham E, Huber L, et al. Combining lefamulin with rifampin provides in vitro synergistic antimicrobial effects against Rhodococcus equi isolates susceptible to macrolides and rifampin. American Journal of Veterinary Research. 2026;87(11). doi:10.2460/ajvr.26.05.0213

BibTeX
@article{Alpini2026,
  author = {Alpini, Sally F O and Seeger, Marlane G and da Silveira, Bibiana P and Cadena, Cierra A and Pham, Elaine and Huber, Laura and Bordin, Angela I and Wu, Jing and Lawhon, Sara D and Cohen, Noah D},
  title = {Combining lefamulin with rifampin provides in vitro synergistic antimicrobial effects against Rhodococcus equi isolates susceptible to macrolides and rifampin},
  journal = {American Journal of Veterinary Research},
  year = {2026},
  volume = {87},
  number = {11},
  doi = {10.2460/ajvr.26.05.0213}
}
Kostenlos starten →